Blood Research

Cited by CrossRef (21)

  1. S. A. Shutov, A. V. Kovalenko, O. A. Soboleva, N. V. Prasolov, K. I. Danishyan. Surgical treatment of the complication of urolithiasis in patients with inhibitor form of hemophilia. Khir. Z. im. N.I. Pirogova 2017:104
    https://doi.org/10.17116/hirurgia20173104-107
  2. R. Hartmann, T. Feenstra, L. Valentino, M. Dockal, F. Scheiflinger. In vitro studies show synergistic effects of a procoagulant bispecific antibody and bypassing agents. Journal of Thrombosis and Haemostasis 2018;16:1580
    https://doi.org/10.1111/jth.14203
  3. Shamsoreza Tabriznia-Tabrizi, Marzie Gholampour, Hassan Mansouritorghabeh. A close insight to factor VIII inhibitor in the congenital hemophilia A. Expert Review of Hematology 2016;9:903
    https://doi.org/10.1080/17474086.2016.1208554
  4. Daniel P. Hart, Charles R.M. Hay, Ri Liesner, Guillermo Tobaruela, Bethan Du-Mont, Mike Makris. Perioperative laboratory monitoring in congenital haemophilia patients with inhibitors. 2019;30:309
    https://doi.org/10.1097/MBC.0000000000000840
  5. Omotola O. Olasupo, Craig Haddix, Charles Nakar, Jennifer Maahs, Anne Greist, Azam Ghafoor, Sharyne M. Donfield, Alfonso Iorio, Amy D. Shapiro. Utilization of a surgical database to provide care and assess perioperative treatment and outcomes in patients with bleeding disorders. European J of Haematology 2022;108:232
    https://doi.org/10.1111/ejh.13731
  6. S.A. Shutov, K.I. Danishyan, N.V. Prasolov, N.I. Zozulya, T.Yu. Polyanskaya, E.A. Kitsenko. Aspects of hemostasis controllability in patients with inhibitory hemophilia during surgery. Endosk. khir. 2022;28:45
    https://doi.org/10.17116/endoskop20222806145
  7. Sibylle A. Kozek-Langenecker, Aamer B. Ahmed, Arash Afshari, Pierre Albaladejo, Cesar Aldecoa, Guidrius Barauskas, Edoardo De Robertis, David Faraoni, Daniela C. Filipescu, Dietmar Fries, Thorsten Haas, Matthias Jacob, Marcus D. Lancé, Juan V.L. Pitarch, Susan Mallett, Jens Meier, Zsolt L. Molnar, Niels Rahe-Meyer, Charles M. Samama, Jakob Stensballe, Philippe J.F. Van der Linden, Anne J. Wikkelsø, Patrick Wouters, Piet Wyffels, Kai Zacharowski. Management of severe perioperative bleeding. 2017;34:332
    https://doi.org/10.1097/EJA.0000000000000630
  8. Omotola O. Olasupo, Charles Nakar, Craig Haddix, Thushara Matthew, Davide Matino, Lynn Malec, Lawrence Mbuagbaw, Jean-Eric Tarride, Alfonso Iorio, Amy D. Shapiro. Inhibitors in hemophilia: association with surgery plans and outcomes in a retrospective cohort study. Research and Practice in Thrombosis and Haemostasis 2023;7:102228
    https://doi.org/10.1016/j.rpth.2023.102228
  9. Gurhan Erturan, Borna Guevel, Abtin Alvand, Nicholas J. Goddard. Over two decades of orthopaedic surgery in patients with inhibitors—Quantifying the complication of bleeding. Haemophilia 2019;25:21
    https://doi.org/10.1111/hae.13647
  10. Jenny Kwak, Michael Mazzeffi, Lisa N. Boggio, Mindy L. Simpson, Kenichi A. Tanaka. Hemophilia: A Review of Perioperative Management for Cardiac Surgery. Journal of Cardiothoracic and Vascular Anesthesia 2022;36:246
    https://doi.org/10.1053/j.jvca.2020.09.118
  11. Victor Jiménez‐Yuste, E. Carlos Rodríguez‐Merchán, Tadashi Matsushita, Pål Andrè Holme. Concomitant use of bypassing agents with emicizumab for people with haemophilia A and inhibitors undergoing surgery. Haemophilia 2021;27:519
    https://doi.org/10.1111/hae.14322
  12. Christian Pfrepper, Paolo Radossi, Jerzy Windyga, Kaan Kavakli, Roger Schutgens, Nazan Sarper, Joan Gu, Kayode Badejo, Nisha Jain. Recombinant porcine factor VIII in patients with congenital haemophilia A with inhibitors undergoing surgery: Phase 3, single‐arm, open‐label study. Haemophilia 2024;30:395
    https://doi.org/10.1111/hae.14932
  13. S.A. Shutov, K.I. Danishyan, A.S. Shutova, G.A. Yatsyk. Acute arterial thrombosis in hemophilia with inhibitory antibodies. Khir. Z. im. N.I. Pirogova 2022:97
    https://doi.org/10.17116/hirurgia202201197
  14. Zühre Kaya, Özlem Orhan, Sacit Turanlı, İdil Yenicesu, Ülker Koçak, Türkiz Gürsel. Successful total hip replacement with sequential administration of bypassing agents in an adolescent boy with hemophilia A and high inhibitor titers. 2017;28:419
    https://doi.org/10.1097/MBC.0000000000000617
  15. Lucia S. D'Angiolella, Paolo A. Cortesi, Angiola Rocino, Antonio Coppola, Hamisa J. Hassan, Adele Giampaolo, Luigi P. Solimeno, Alessandra Lafranconi, Mariangela Micale, Sveva Mangano, Giacomo Crotti, Federica Pagliarin, Giancarlo Cesana, Lorenzo G. Mantovani. The socioeconomic burden of patients affected by hemophilia with inhibitors. European J of Haematology 2018;101:435
    https://doi.org/10.1111/ejh.13108
  16. Rie Shirayama, Hideyuki Takedani, Yushi Chikasawa, Akira Ishiguro, Masataka Ishimura, Kiyotaka Isobe, Mitsuhiro Uchiba, Yoshiyasu Ogata, Harumi Kakuda, Koichi Kusuhara, Akira Shirahata. Perioperative safety and haematostatic efficacy of a new bypassing agent pd-FVIIa/FX (Byclot) in haemophilia patients with high-responding type inhibitors. 2019;30:385
    https://doi.org/10.1097/MBC.0000000000000851
  17. Steven W. Pipe, Amy L. Dunn, Guy Young. Efficacy and safety evaluation of eptacog beta (coagulation factor VIIa [recombinant]-jncw) for the treatment of hemophilia A and B with inhibitors. Expert Review of Hematology 2023;16:715
    https://doi.org/10.1080/17474086.2023.2248385
  18. Flora Peyvandi, Kaan Kavakli, Amal El‐Beshlawy, Savita Rangarajan. Management of haemophilia A with inhibitors: A regional cross‐talk. Haemophilia 2022;28:950
    https://doi.org/10.1111/hae.14638
  19. Miguel Escobar, James Luck, Yevhenii Averianov, Jonathan Ducore, Maria Fernanda López Fernández, Adam Giermasz, Daniel P. Hart, Janna Journeycake, Craig Kessler, Cindy Leissinger, Johnny Mahlangu, Laura Villarreal Martinez, Wolfgang Miesbach, Ismail Haroon Mitha, Doris Quon, Mark T. Reding, Jean‐François Schved, Oleksandra Stasyshyn, Kateryna V. Vilchevska, Michael Wang, Jerzy Windyga, W. Allan Alexander, Ahmad Al‐Sabbagh, Daniel Bonzo, Ian S. Mitchell, Thomas A. Wilkinson, Cédric Hermans. PERSEPT 3: A phase 3 clinical trial to evaluate the haemostatic efficacy of eptacog beta (recombinant human FVIIa) in perioperative care in subjects with haemophilia A or B with inhibitors. Haemophilia 2021;27:911
    https://doi.org/10.1111/hae.14418
  20. Rudolf Hartmann, Tjerk Feenstra, Sabine Knappe, Gerald Schrenk, Friedrich Scheiflinger, Michael Dockal. A bispecific antibody demonstrates limited measurability in routine coagulation assays. 2020;31:353
    https://doi.org/10.1097/MBC.0000000000000921
  21. Sénadé Atsou, Célia Schellenberg, Jeremy Lagrange, Patrick Lacolley, Peter J. Lenting, Cécile V. Denis, Olivier D. Christophe, Véronique Regnault. Thrombin generation on vascular cells in the presence of factor VIII and/or emicizumab. Journal of Thrombosis and Haemostasis 2024;22:112
    https://doi.org/10.1016/j.jtha.2023.09.017
© 2024. BLOOD RESEARCH All rights reserved. Powered by INFOrang Co., Ltd